Drugs for Anti-Infective Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Drugs for Anti-Infective Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Anti-Infective Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Anti-Infective Overall Market Size
2.1 Global Drugs for Anti-Infective Market Size: 2021 VS 2027
2.2 Global Drugs for Anti-Infective Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Drugs for Anti-Infective Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Drugs for Anti-Infective Players in Global Market
3.2 Top Global Drugs for Anti-Infective Companies Ranked by Revenue
3.3 Global Drugs for Anti-Infective Revenue by Companies
3.4 Global Drugs for Anti-Infective Sales by Companies
3.5 Global Drugs for Anti-Infective Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Drugs for Anti-Infective Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Drugs for Anti-Infective Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drugs for Anti-Infective Players in Global Market
3.8.1 List of Global Tier 1 Drugs for Anti-Infective Companies
3.8.2 List of Global Tier 2 and Tier 3 Drugs for Anti-Infective Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Anti-Infective Market Size Markets, 2021 & 2027
4.1.2 OTC
4.1.3 Rx Drugs
4.2 By Type - Global Drugs for Anti-Infective Revenue & Forecasts
4.2.1 By Type - Global Drugs for Anti-Infective Revenue, 2016-2021
4.2.2 By Type - Global Drugs for Anti-Infective Revenue, 2022-2027
4.2.3 By Type - Global Drugs for Anti-Infective Revenue Market Share, 2016-2027
4.3 By Type - Global Drugs for Anti-Infective Sales & Forecasts
4.3.1 By Type - Global Drugs for Anti-Infective Sales, 2016-2021
4.3.2 By Type - Global Drugs for Anti-Infective Sales, 2022-2027
4.3.3 By Type - Global Drugs for Anti-Infective Sales Market Share, 2016-2027
4.4 By Type - Global Drugs for Anti-Infective Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Anti-Infective Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Drugs Store
5.1.4 Other
5.2 By Application - Global Drugs for Anti-Infective Revenue & Forecasts
5.2.1 By Application - Global Drugs for Anti-Infective Revenue, 2016-2021
5.2.2 By Application - Global Drugs for Anti-Infective Revenue, 2022-2027
5.2.3 By Application - Global Drugs for Anti-Infective Revenue Market Share, 2016-2027
5.3 By Application - Global Drugs for Anti-Infective Sales & Forecasts
5.3.1 By Application - Global Drugs for Anti-Infective Sales, 2016-2021
5.3.2 By Application - Global Drugs for Anti-Infective Sales, 2022-2027
5.3.3 By Application - Global Drugs for Anti-Infective Sales Market Share, 2016-2027
5.4 By Application - Global Drugs for Anti-Infective Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Drugs for Anti-Infective Market Size, 2021 & 2027
6.2 By Region - Global Drugs for Anti-Infective Revenue & Forecasts
6.2.1 By Region - Global Drugs for Anti-Infective Revenue, 2016-2021
6.2.2 By Region - Global Drugs for Anti-Infective Revenue, 2022-2027
6.2.3 By Region - Global Drugs for Anti-Infective Revenue Market Share, 2016-2027
6.3 By Region - Global Drugs for Anti-Infective Sales & Forecasts
6.3.1 By Region - Global Drugs for Anti-Infective Sales, 2016-2021
6.3.2 By Region - Global Drugs for Anti-Infective Sales, 2022-2027
6.3.3 By Region - Global Drugs for Anti-Infective Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Drugs for Anti-Infective Revenue, 2016-2027
6.4.2 By Country - North America Drugs for Anti-Infective Sales, 2016-2027
6.4.3 US Drugs for Anti-Infective Market Size, 2016-2027
6.4.4 Canada Drugs for Anti-Infective Market Size, 2016-2027
6.4.5 Mexico Drugs for Anti-Infective Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Drugs for Anti-Infective Revenue, 2016-2027
6.5.2 By Country - Europe Drugs for Anti-Infective Sales, 2016-2027
6.5.3 Germany Drugs for Anti-Infective Market Size, 2016-2027
6.5.4 France Drugs for Anti-Infective Market Size, 2016-2027
6.5.5 U.K. Drugs for Anti-Infective Market Size, 2016-2027
6.5.6 Italy Drugs for Anti-Infective Market Size, 2016-2027
6.5.7 Russia Drugs for Anti-Infective Market Size, 2016-2027
6.5.8 Nordic Countries Drugs for Anti-Infective Market Size, 2016-2027
6.5.9 Benelux Drugs for Anti-Infective Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Drugs for Anti-Infective Revenue, 2016-2027
6.6.2 By Region - Asia Drugs for Anti-Infective Sales, 2016-2027
6.6.3 China Drugs for Anti-Infective Market Size, 2016-2027
6.6.4 Japan Drugs for Anti-Infective Market Size, 2016-2027
6.6.5 South Korea Drugs for Anti-Infective Market Size, 2016-2027
6.6.6 Southeast Asia Drugs for Anti-Infective Market Size, 2016-2027
6.6.7 India Drugs for Anti-Infective Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Drugs for Anti-Infective Revenue, 2016-2027
6.7.2 By Country - South America Drugs for Anti-Infective Sales, 2016-2027
6.7.3 Brazil Drugs for Anti-Infective Market Size, 2016-2027
6.7.4 Argentina Drugs for Anti-Infective Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Drugs for Anti-Infective Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Drugs for Anti-Infective Sales, 2016-2027
6.8.3 Turkey Drugs for Anti-Infective Market Size, 2016-2027
6.8.4 Israel Drugs for Anti-Infective Market Size, 2016-2027
6.8.5 Saudi Arabia Drugs for Anti-Infective Market Size, 2016-2027
6.8.6 UAE Drugs for Anti-Infective Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Drugs for Anti-Infective Major Product Offerings
7.1.4 GlaxoSmithKline Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.1.5 GlaxoSmithKline Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Drugs for Anti-Infective Major Product Offerings
7.2.4 Merck Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.2.5 Merck Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Drugs for Anti-Infective Major Product Offerings
7.3.4 Pfizer Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.3.5 Pfizer Key News
7.4 Novartis AG
7.4.1 Novartis AG Corporate Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Drugs for Anti-Infective Major Product Offerings
7.4.4 Novartis AG Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.4.5 Novartis AG Key News
7.5 Gilead Sciences
7.5.1 Gilead Sciences Corporate Summary
7.5.2 Gilead Sciences Business Overview
7.5.3 Gilead Sciences Drugs for Anti-Infective Major Product Offerings
7.5.4 Gilead Sciences Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.5.5 Gilead Sciences Key News
7.6 Abbott
7.6.1 Abbott Corporate Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Drugs for Anti-Infective Major Product Offerings
7.6.4 Abbott Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.6.5 Abbott Key News
7.7 Wyeth
7.7.1 Wyeth Corporate Summary
7.7.2 Wyeth Business Overview
7.7.3 Wyeth Drugs for Anti-Infective Major Product Offerings
7.4.4 Wyeth Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.7.5 Wyeth Key News
7.8 Sanofi-Aventis
7.8.1 Sanofi-Aventis Corporate Summary
7.8.2 Sanofi-Aventis Business Overview
7.8.3 Sanofi-Aventis Drugs for Anti-Infective Major Product Offerings
7.8.4 Sanofi-Aventis Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.8.5 Sanofi-Aventis Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Drugs for Anti-Infective Major Product Offerings
7.9.4 Bristol-Myers Squibb Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.9.5 Bristol-Myers Squibb Key News
7.10 Johnson
7.10.1 Johnson Corporate Summary
7.10.2 Johnson Business Overview
7.10.3 Johnson Drugs for Anti-Infective Major Product Offerings
7.10.4 Johnson Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.10.5 Johnson Key News
7.11 Roche Pharma AG
7.11.1 Roche Pharma AG Corporate Summary
7.11.2 Roche Pharma AG Drugs for Anti-Infective Business Overview
7.11.3 Roche Pharma AG Drugs for Anti-Infective Major Product Offerings
7.11.4 Roche Pharma AG Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.11.5 Roche Pharma AG Key News
7.12 Nanosphere
7.12.1 Nanosphere Corporate Summary
7.12.2 Nanosphere Drugs for Anti-Infective Business Overview
7.12.3 Nanosphere Drugs for Anti-Infective Major Product Offerings
7.12.4 Nanosphere Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.12.5 Nanosphere Key News
7.13 NanoViricides
7.13.1 NanoViricides Corporate Summary
7.13.2 NanoViricides Drugs for Anti-Infective Business Overview
7.13.3 NanoViricides Drugs for Anti-Infective Major Product Offerings
7.13.4 NanoViricides Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.13.5 NanoViricides Key News
7.14 Novabay Pharmaceuticals
7.14.1 Novabay Pharmaceuticals Corporate Summary
7.14.2 Novabay Pharmaceuticals Business Overview
7.14.3 Novabay Pharmaceuticals Drugs for Anti-Infective Major Product Offerings
7.14.4 Novabay Pharmaceuticals Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.14.5 Novabay Pharmaceuticals Key News
7.15 Obetech
7.15.1 Obetech Corporate Summary
7.15.2 Obetech Business Overview
7.15.3 Obetech Drugs for Anti-Infective Major Product Offerings
7.15.4 Obetech Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.15.5 Obetech Key News
7.16 Optimer Pharmaceuticals
7.16.1 Optimer Pharmaceuticals Corporate Summary
7.16.2 Optimer Pharmaceuticals Business Overview
7.16.3 Optimer Pharmaceuticals Drugs for Anti-Infective Major Product Offerings
7.16.4 Optimer Pharmaceuticals Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.16.5 Optimer Pharmaceuticals Key News
7.17 Basilea Pharmaceutica AG
7.17.1 Basilea Pharmaceutica AG Corporate Summary
7.17.2 Basilea Pharmaceutica AG Business Overview
7.17.3 Basilea Pharmaceutica AG Drugs for Anti-Infective Major Product Offerings
7.17.4 Basilea Pharmaceutica AG Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.17.5 Basilea Pharmaceutica AG Key News
7.18 Daiichi Sankyo
7.18.1 Daiichi Sankyo Corporate Summary
7.18.2 Daiichi Sankyo Business Overview
7.18.3 Daiichi Sankyo Drugs for Anti-Infective Major Product Offerings
7.18.4 Daiichi Sankyo Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.18.5 Daiichi Sankyo Key News
7.19 MerLion Pharma
7.19.1 MerLion Pharma Corporate Summary
7.19.2 MerLion Pharma Business Overview
7.19.3 MerLion Pharma Drugs for Anti-Infective Major Product Offerings
7.19.4 MerLion Pharma Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.19.5 MerLion Pharma Key News
7.20 Theravance
7.20.1 Theravance Corporate Summary
7.20.2 Theravance Business Overview
7.20.3 Theravance Drugs for Anti-Infective Major Product Offerings
7.20.4 Theravance Drugs for Anti-Infective Sales and Revenue in Global (2016-2021)
7.20.5 Theravance Key News
8 Global Drugs for Anti-Infective Production Capacity, Analysis
8.1 Global Drugs for Anti-Infective Production Capacity, 2016-2027
8.2 Drugs for Anti-Infective Production Capacity of Key Manufacturers in Global Market
8.3 Global Drugs for Anti-Infective Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Drugs for Anti-Infective Supply Chain Analysis
10.1 Drugs for Anti-Infective Industry Value Chain
10.2 Drugs for Anti-Infective Upstream Market
10.3 Drugs for Anti-Infective Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Drugs for Anti-Infective Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Drugs for Anti-Infective in Global Market
Table 2. Top Drugs for Anti-Infective Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Drugs for Anti-Infective Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Drugs for Anti-Infective Revenue Share by Companies, 2016-2021
Table 5. Global Drugs for Anti-Infective Sales by Companies, (K Units), 2016-2021
Table 6. Global Drugs for Anti-Infective Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Drugs for Anti-Infective Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Drugs for Anti-Infective Product Type
Table 9. List of Global Tier 1 Drugs for Anti-Infective Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Anti-Infective Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Drugs for Anti-Infective Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Drugs for Anti-Infective Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Drugs for Anti-Infective Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Drugs for Anti-Infective Sales (K Units), 2016-2021
Table 15. By Type - Global Drugs for Anti-Infective Sales (K Units), 2022-2027
Table 16. By Application - Global Drugs for Anti-Infective Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Drugs for Anti-Infective Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Drugs for Anti-Infective Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Drugs for Anti-Infective Sales (K Units), 2016-2021
Table 20. By Application - Global Drugs for Anti-Infective Sales (K Units), 2022-2027
Table 21. By Region - Global Drugs for Anti-Infective Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Drugs for Anti-Infective Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Drugs for Anti-Infective Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Drugs for Anti-Infective Sales (K Units), 2016-2021
Table 25. By Region - Global Drugs for Anti-Infective Sales (K Units), 2022-2027
Table 26. By Country - North America Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Drugs for Anti-Infective Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Drugs for Anti-Infective Sales, (K Units), 2016-2021
Table 29. By Country - North America Drugs for Anti-Infective Sales, (K Units), 2022-2027
Table 30. By Country - Europe Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Drugs for Anti-Infective Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Drugs for Anti-Infective Sales, (K Units), 2016-2021
Table 33. By Country - Europe Drugs for Anti-Infective Sales, (K Units), 2022-2027
Table 34. By Region - Asia Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Drugs for Anti-Infective Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Drugs for Anti-Infective Sales, (K Units), 2016-2021
Table 37. By Region - Asia Drugs for Anti-Infective Sales, (K Units), 2022-2027
Table 38. By Country - South America Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Drugs for Anti-Infective Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Drugs for Anti-Infective Sales, (K Units), 2016-2021
Table 41. By Country - South America Drugs for Anti-Infective Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Drugs for Anti-Infective Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Drugs for Anti-Infective Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Drugs for Anti-Infective Sales, (K Units), 2022-2027
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Drugs for Anti-Infective Product Offerings
Table 48. GlaxoSmithKline Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Merck Corporate Summary
Table 50. Merck Drugs for Anti-Infective Product Offerings
Table 51. Merck Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Drugs for Anti-Infective Product Offerings
Table 54. Pfizer Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Novartis AG Corporate Summary
Table 56. Novartis AG Drugs for Anti-Infective Product Offerings
Table 57. Novartis AG Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Gilead Sciences Corporate Summary
Table 59. Gilead Sciences Drugs for Anti-Infective Product Offerings
Table 60. Gilead Sciences Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Abbott Corporate Summary
Table 62. Abbott Drugs for Anti-Infective Product Offerings
Table 63. Abbott Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Wyeth Corporate Summary
Table 65. Wyeth Drugs for Anti-Infective Product Offerings
Table 66. Wyeth Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Sanofi-Aventis Corporate Summary
Table 68. Sanofi-Aventis Drugs for Anti-Infective Product Offerings
Table 69. Sanofi-Aventis Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. Bristol-Myers Squibb Corporate Summary
Table 71. Bristol-Myers Squibb Drugs for Anti-Infective Product Offerings
Table 72. Bristol-Myers Squibb Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 73. Johnson Corporate Summary
Table 74. Johnson Drugs for Anti-Infective Product Offerings
Table 75. Johnson Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 76. Roche Pharma AG Corporate Summary
Table 77. Roche Pharma AG Drugs for Anti-Infective Product Offerings
Table 78. Roche Pharma AG Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 79. Nanosphere Corporate Summary
Table 80. Nanosphere Drugs for Anti-Infective Product Offerings
Table 81. Nanosphere Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 82. NanoViricides Corporate Summary
Table 83. NanoViricides Drugs for Anti-Infective Product Offerings
Table 84. NanoViricides Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 85. Novabay Pharmaceuticals Corporate Summary
Table 86. Novabay Pharmaceuticals Drugs for Anti-Infective Product Offerings
Table 87. Novabay Pharmaceuticals Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 88. Obetech Corporate Summary
Table 89. Obetech Drugs for Anti-Infective Product Offerings
Table 90. Obetech Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 91. Optimer Pharmaceuticals Corporate Summary
Table 92. Optimer Pharmaceuticals Drugs for Anti-Infective Product Offerings
Table 93. Optimer Pharmaceuticals Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 94. Basilea Pharmaceutica AG Corporate Summary
Table 95. Basilea Pharmaceutica AG Drugs for Anti-Infective Product Offerings
Table 96. Basilea Pharmaceutica AG Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 97. Daiichi Sankyo Corporate Summary
Table 98. Daiichi Sankyo Drugs for Anti-Infective Product Offerings
Table 99. Daiichi Sankyo Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 100. MerLion Pharma Corporate Summary
Table 101. MerLion Pharma Drugs for Anti-Infective Product Offerings
Table 102. MerLion Pharma Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 103. Theravance Corporate Summary
Table 104. Theravance Drugs for Anti-Infective Product Offerings
Table 105. Theravance Drugs for Anti-Infective Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 106. Drugs for Anti-Infective Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 107. Global Drugs for Anti-Infective Capacity Market Share of Key Manufacturers, 2019-2021
Table 108. Global Drugs for Anti-Infective Production by Region, 2016-2021 (K Units)
Table 109. Global Drugs for Anti-Infective Production by Region, 2022-2027 (K Units)
Table 110. Drugs for Anti-Infective Market Opportunities & Trends in Global Market
Table 111. Drugs for Anti-Infective Market Drivers in Global Market
Table 112. Drugs for Anti-Infective Market Restraints in Global Market
Table 113. Drugs for Anti-Infective Raw Materials
Table 114. Drugs for Anti-Infective Raw Materials Suppliers in Global Market
Table 115. Typical Drugs for Anti-Infective Downstream
Table 116. Drugs for Anti-Infective Downstream Clients in Global Market
Table 117. Drugs for Anti-Infective Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Drugs for Anti-Infective Segment by Type
Figure 2. Drugs for Anti-Infective Segment by Application
Figure 3. Global Drugs for Anti-Infective Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Drugs for Anti-Infective Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Drugs for Anti-Infective Revenue, 2016-2027 (US$, Mn)
Figure 7. Drugs for Anti-Infective Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Drugs for Anti-Infective Revenue in 2020
Figure 9. By Type - Global Drugs for Anti-Infective Sales Market Share, 2016-2027
Figure 10. By Type - Global Drugs for Anti-Infective Revenue Market Share, 2016-2027
Figure 11. By Type - Global Drugs for Anti-Infective Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Drugs for Anti-Infective Sales Market Share, 2016-2027
Figure 13. By Application - Global Drugs for Anti-Infective Revenue Market Share, 2016-2027
Figure 14. By Application - Global Drugs for Anti-Infective Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Drugs for Anti-Infective Sales Market Share, 2016-2027
Figure 16. By Region - Global Drugs for Anti-Infective Revenue Market Share, 2016-2027
Figure 17. By Country - North America Drugs for Anti-Infective Revenue Market Share, 2016-2027
Figure 18. By Country - North America Drugs for Anti-Infective Sales Market Share, 2016-2027
Figure 19. US Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Drugs for Anti-Infective Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Drugs for Anti-Infective Sales Market Share, 2016-2027
Figure 24. Germany Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 25. France Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Drugs for Anti-Infective Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Drugs for Anti-Infective Sales Market Share, 2016-2027
Figure 33. China Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 37. India Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Drugs for Anti-Infective Revenue Market Share, 2016-2027
Figure 39. By Country - South America Drugs for Anti-Infective Sales Market Share, 2016-2027
Figure 40. Brazil Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Drugs for Anti-Infective Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Drugs for Anti-Infective Sales Market Share, 2016-2027
Figure 44. Turkey Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Drugs for Anti-Infective Revenue, (US$, Mn), 2016-2027
Figure 48. Global Drugs for Anti-Infective Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Drugs for Anti-Infective by Region, 2020 VS 2027
Figure 50. Drugs for Anti-Infective Industry Value Chain
Figure 51. Marketing Channels

GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Wyeth
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo
MerLion Pharma
Theravance